Chlorogenic Acid Blood Glucose Meta-analysis: What the Evidence Says

Quick Answer

Chlorogenic Acid Blood Glucose Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• MMC administration in a rat model of type 2 diabetes mellitus (T2DM) significantly reduced blood glucose, insulin, and lipid levels. [Chen Jia (2026); evidence level 3]
• Infographic showing mulberry leaf mechanisms for controlling blood glucose: delayed glucose absorption in the small intestine, maintained insulin secretion in the pancreas, enhanced insulin sensitivity in peripheral tissues, and reduced hepatic glucose output with increased glycogen synthesis in the liver. [Chen Jia (2026); evidence level 3]
• All participants met the classification of being Tier 2 athletes, and habitual caffeine use was chosen to minimize the risk of adverse events from unaccustomed caffeine intake. [Pavis George F. (2026); evidence level 4]
• From baseline, plasma caffeine concentration remained unchanged with PLA throughout SS, but was elevated by CB immediately prior to, and at 10, 20 and 30&#8201;mins of SS (interaction&#8201;<&#8201;0.001; all timepoints increased from baseline, and greater than PLA; post hoc&#8201;<&#8201;0.001). [Pavis George F. (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For chlorogenic acid blood glucose meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Chen Jia (2026). New directions in mulberry leaf research for diabetes: a translational approach based on multi-component synergy. DOI: 10.3389/fnut.2026.1792767. PMCID: PMC13111556. PMID: 42051334. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13111556/
• Pavis George F. (2026). An extract from whole Coffea arabica coffee cherry improves time trial performance, but not muscle glycogen resynthesis, in trained cyclists. DOI: 10.1080/15502783.2026.2682323. PMCID: PMC13235231. PMID: 42234539. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13235231/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.